Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil.

Poli E, Kounis I, Guettier C, Verstuyft C, Coilly A, Sobesky R, Feray C, Vibert E, Ciacio O, Samuel D, Bismuth H, Duclos-Vallée JC.

Hepatology. 2019 Oct 9. doi: 10.1002/hep.30984. [Epub ahead of print]

PMID:
31597193
2.

Tspan15 Is a New Stemness-Related Marker in Hepatocellular Carcinoma.

Sidahmed-Adrar N, Ottavi JF, Benzoubir N, Ait Saadi T, Bou Saleh M, Mauduit P, Guettier C, Desterke C, Le Naour F.

Proteomics. 2019 Aug 7:e1900025. doi: 10.1002/pmic.201900025. [Epub ahead of print]

PMID:
31390680
3.

Adeno-associated virus in the liver: natural history and consequences in tumour development.

La Bella T, Imbeaud S, Peneau C, Mami I, Datta S, Bayard Q, Caruso S, Hirsch TZ, Calderaro J, Morcrette G, Guettier C, Paradis V, Amaddeo G, Laurent A, Possenti L, Chiche L, Bioulac-Sage P, Blanc JF, Letouze E, Nault JC, Zucman-Rossi J.

Gut. 2019 Aug 2. pii: gutjnl-2019-318281. doi: 10.1136/gutjnl-2019-318281. [Epub ahead of print]

PMID:
31375600
4.

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures.

Morcrette G, Hirsch TZ, Badour E, Pilet J, Caruso S, Calderaro J, Martin Y, Imbeaud S, Letouzé E, Rebouissou S, Branchereau S, Taque S, Chardot C, Guettier C, Scoazec JY, Fabre M, Brugières L, Zucman-Rossi J.

Oncoimmunology. 2019 Mar 28;8(6):e1583547. doi: 10.1080/2162402X.2019.1583547. eCollection 2019.

5.

Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.

Nitta H, Allard MA, Sebagh M, Ciacio O, Pittau G, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Guettier C, Lewin M, Samuel D, Baba H, Adam R.

Ann Surg Oncol. 2019 Aug;26(8):2568-2576. doi: 10.1245/s10434-019-07365-0. Epub 2019 May 3.

PMID:
31054040
6.

[Telepathology for intra-operative frozen sections].

Laurent-Bellue A, Poullier E, Prevot S, Guettier C.

Ann Pathol. 2019 Apr;39(2):113-118. doi: 10.1016/j.annpat.2019.02.010. Epub 2019 Mar 28. French. No abstract available.

PMID:
30928255
7.

Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation.

Nitta H, Allard MA, Sebagh M, Karam V, Ciacio O, Pittau G, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Guettier C, Samuel D, Baba H, Adam R.

Surgery. 2019 Jun;165(6):1168-1175. doi: 10.1016/j.surg.2019.01.012. Epub 2019 Mar 14.

PMID:
30878140
8.

TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function.

Merlen G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, Simerabet H, Doignon I, Tanfin Z, Garcin I, Péan N, Gautherot J, Davit-Spraul A, Guettier C, Humbert L, Rainteau D, Ebnet K, Ullmer C, Cassio D, Tordjmann T.

Gut. 2019 Feb 5. pii: gutjnl-2018-316975. doi: 10.1136/gutjnl-2018-316975. [Epub ahead of print]

PMID:
30723104
9.

Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2019 Mar;70(3):566-567. doi: 10.1016/j.jhep.2018.11.016. Epub 2018 Dec 5. No abstract available.

PMID:
30527952
10.

Liver transplantation in patients with liver failure related to exertional heatstroke.

Ichai P, Laurent-Bellue A, Camus C, Moreau D, Boutonnet M, Saliba F, Peron JM, Ichai C, Gregoire E, Aigle L, Cousty J, Quinart A, Pons B, Boudon M, André S, Coilly A, Antonini T, Guettier C, Samuel D.

J Hepatol. 2019 Mar;70(3):431-439. doi: 10.1016/j.jhep.2018.11.024. Epub 2018 Dec 4.

PMID:
30521841
11.

Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood.

Gonzales E, Matarazzo L, Franchi-Abella S, Dabadie A, Cohen J, Habes D, Hillaire S, Guettier C, Taburet AM, Myara A, Jacquemin E.

Orphanet J Rare Dis. 2018 Oct 29;13(1):190. doi: 10.1186/s13023-018-0920-5.

12.

Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Dec;69(6):1397-1398. doi: 10.1016/j.jhep.2018.09.006. Epub 2018 Oct 5. No abstract available.

PMID:
30297274
13.

[Hepatic and digestive adverse events of immune checkpoint inhibitors (anti-CTLA-4 and, anti-PD-1/PD-L1): A clinico-pathological review].

Papouin B, Mussini C, De Martin E, Guettier C.

Ann Pathol. 2018 Dec;38(6):338-351. doi: 10.1016/j.annpat.2018.07.005. Epub 2018 Aug 22. Review. French.

PMID:
30143243
14.

Reply to: "Mortality due to immunotherapy related hepatitis".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Oct;69(4):978-979. doi: 10.1016/j.jhep.2018.07.009. Epub 2018 Aug 7. No abstract available.

PMID:
30097327
15.

The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis.

Le Guilcher C, Garcin I, Dellis O, Cauchois F, Tebbi A, Doignon I, Guettier C, Julien B, Tordjmann T.

J Hepatol. 2018 Sep;69(3):644-653. doi: 10.1016/j.jhep.2018.05.020. Epub 2018 May 24.

PMID:
29802948
16.

Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

De Martin E, Michot JM, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Aug;69(2):550-551. doi: 10.1016/j.jhep.2018.04.019. No abstract available.

PMID:
29776713
17.

Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.

Dao M, Habès D, Taupin JL, Mussini C, Redon MJ, Suberbielle C, Jacquemin E, Gonzales E, Guettier C.

Liver Transpl. 2018 Jul;24(7):897-907. doi: 10.1002/lt.25187.

18.

BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient.

Dao M, Pécriaux A, Bessede T, Dürrbach A, Mussini C, Guettier C, Ferlicot S.

Oncotarget. 2018 Feb 22;9(19):15157-15163. doi: 10.18632/oncotarget.24552. eCollection 2018 Mar 13.

19.

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.

De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O, Roche B, Antonini TM, Coilly A, Laghouati S, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.

PMID:
29427729
20.

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.

Indersie E, Lesjean S, Hooks KB, Sagliocco F, Ernault T, Cairo S, Merched-Sauvage M, Rullier A, Le Bail B, Taque S, Grotzer M, Branchereau S, Guettier C, Fabre M, Brugières L, Hagedorn M, Buendia MA, Grosset CF.

Hepatol Commun. 2017 Apr 6;1(2):168-183. doi: 10.1002/hep4.1029. eCollection 2017 Apr.

21.

Long-term outcome of liver transplantation in childhood: A study of 20-year survivors.

Martinelli J, Habes D, Majed L, Guettier C, Gonzalès E, Linglart A, Larue C, Furlan V, Pariente D, Baujard C, Branchereau S, Gauthier F, Jacquemin E, Bernard O.

Am J Transplant. 2018 Jul;18(7):1680-1689. doi: 10.1111/ajt.14626. Epub 2018 Jan 12.

22.

New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.

Hooks KB, Audoux J, Fazli H, Lesjean S, Ernault T, Dugot-Senant N, Leste-Lasserre T, Hagedorn M, Rousseau B, Danet C, Branchereau S, Brugières L, Taque S, Guettier C, Fabre M, Rullier A, Buendia MA, Commes T, Grosset CF, Raymond AA.

Hepatology. 2018 Jul;68(1):89-102. doi: 10.1002/hep.29672. Epub 2018 May 14.

PMID:
29152775
23.

Rhabdoid tumor of the liver: Report of 6 pediatric cases treated at a single institute.

Cornet M, De Lambert G, Pariente D, Planchon JM, Guettier C, Martelli H, Guérin F, Branchereau S.

J Pediatr Surg. 2018 Mar;53(3):567-571. doi: 10.1016/j.jpedsurg.2017.09.005. Epub 2017 Sep 14.

PMID:
28966010
24.

Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma.

Crippa S, Ancey PB, Vazquez J, Angelino P, Rougemont AL, Guettier C, Zoete V, Delorenzi M, Michielin O, Meylan E.

EMBO Mol Med. 2017 Nov;9(11):1589-1604. doi: 10.15252/emmm.201707814.

25.

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.

Saffroy R, Morère JF, Bosselut N, Innominato PF, Hamelin J, Trédaniel J, Masse S, Dussaule-Duchatelle V, Balaton A, Validire P, Guettier C, Bouchahda M, Lemoine A.

Oncotarget. 2017 Feb 7;8(31):50792-50803. doi: 10.18632/oncotarget.15132. eCollection 2017 Aug 1.

26.

Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy.

Besmond C, Valla D, Hubert L, Poirier K, Grosse B, Guettier C, Bernard O, Gonzales E, Jacquemin E.

Liver Int. 2018 Feb;38(2):358-364. doi: 10.1111/liv.13547. Epub 2017 Sep 12.

PMID:
28792652
27.

Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma.

Rajakannu M, Cherqui D, Ciacio O, Golse N, Pittau G, Allard MA, Antonini TM, Coilly A, Sa Cunha A, Castaing D, Samuel D, Guettier C, Adam R, Vibert E.

Surgery. 2017 Oct;162(4):766-774. doi: 10.1016/j.surg.2017.06.006. Epub 2017 Jul 12.

PMID:
28711320
28.

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients.

Chiappini F, Coilly A, Kadar H, Gual P, Tran A, Desterke C, Samuel D, Duclos-Vallée JC, Touboul D, Bertrand-Michel J, Brunelle A, Guettier C, Le Naour F.

Sci Rep. 2017 Apr 24;7:46658. doi: 10.1038/srep46658.

29.

Critical cholangiocarcinogenesis control by cryptochrome clock genes.

Mteyrek A, Filipski E, Guettier C, Oklejewicz M, van der Horst GT, Okyar A, Lévi F.

Int J Cancer. 2017 Jun 1;140(11):2473-2483. doi: 10.1002/ijc.30663. Epub 2017 Mar 16.

30.

Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.

Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, Valeyrie-Allanore L, Bretagne SR, Boudon M, Antonini TM, Artru F, Pittau G, Roux O, Azoulay D, Levesque E, Durand F, Guettier C, Samuel D.

Transplantation. 2017 Aug;101(8):1830-1837. doi: 10.1097/TP.0000000000001655.

PMID:
28207633
31.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S; GENTHEP Investigators, Bioulac-Sage P, Letouzé E, Zucman-Rossi J.

Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.

32.

MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.

Gonzales E, Taylor SA, Davit-Spraul A, Thébaut A, Thomassin N, Guettier C, Whitington PF, Jacquemin E.

Hepatology. 2017 Jan;65(1):164-173. doi: 10.1002/hep.28779. Epub 2016 Oct 5.

PMID:
27532546
33.

Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.

Chiappini F, Desterke C, Bertrand-Michel J, Guettier C, Le Naour F.

Sci Rep. 2016 Aug 11;6:31587. doi: 10.1038/srep31587.

34.

Rapid and reliable diagnosis of Wilson disease using X-ray fluorescence.

Kaščáková S, Kewish CM, Rouzière S, Schmitt F, Sobesky R, Poupon J, Sandt C, Francou B, Somogyi A, Samuel D, Jacquemin E, Dubart-Kupperschmitt A, Nguyen TH, Bazin D, Duclos-Vallée JC, Guettier C, Le Naour F.

J Pathol Clin Res. 2016 Jun 6;2(3):175-86. doi: 10.1002/cjp2.48. eCollection 2016 Jul.

35.

Clock gene Per2 as a controller of liver carcinogenesis.

Mteyrek A, Filipski E, Guettier C, Okyar A, Lévi F.

Oncotarget. 2016 Dec 27;7(52):85832-85847. doi: 10.18632/oncotarget.11037.

36.

DCDC2 Mutations Cause Neonatal Sclerosing Cholangitis.

Girard M, Bizet AA, Lachaux A, Gonzales E, Filhol E, Collardeau-Frachon S, Jeanpierre C, Henry C, Fabre M, Viremouneix L, Galmiche L, Debray D, Bole-Feysot C, Nitschke P, Pariente D, Guettier C, Lyonnet S, Heidet L, Bertholet A, Jacquemin E, Henrion-Caude A, Saunier S.

Hum Mutat. 2016 Oct;37(10):1025-9. doi: 10.1002/humu.23031. Epub 2016 Aug 24.

PMID:
27319779
37.

Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma.

Cros J, Sbidian E, Posseme K, Letierce A, Guettier C, Benoît G, Ferlicot S.

Virchows Arch. 2016 Sep;469(3):331-7. doi: 10.1007/s00428-016-1973-2. Epub 2016 Jun 17.

PMID:
27311769
38.

Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.

Nicolle D, Fabre M, Simon-Coma M, Gorse A, Kappler R, Nonell L, Mallo M, Haidar H, Déas O, Mussini C, Guettier C, Redon MJ, Brugières L, Ghigna MR, Fadel E, Galmiche-Rolland L, Chardot C, Judde JG, Armengol C, Branchereau S, Cairo S.

Hepatology. 2016 Oct;64(4):1121-35. doi: 10.1002/hep.28621. Epub 2016 Jun 16.

PMID:
27115099
39.

Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.

Mustafa MZ, Nguyen VH, Le Naour F, De Martin E, Beleoken E, Guettier C, Johanet C, Samuel D, Duclos-Vallee JC, Ballot E.

J Transl Med. 2016 Jan 16;14:17. doi: 10.1186/s12967-015-0751-2.

40.

Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature.

Peng C, Kaščáková S, Chiappini F, Olaya N, Sandt C, Yousef I, Samuel D, Dumas P, Guettier C, Le Naour F.

J Transl Med. 2016 Jan 12;14:9. doi: 10.1186/s12967-016-0763-6.

41.

Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?

Bhangui P, Allard MA, Vibert E, Cherqui D, Pelletier G, Cunha AS, Guettier C, Vallee JC, Saliba F, Bismuth H, Samuel D, Castaing D, Adam R.

Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442.

PMID:
26649581
42.

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

Pujals A, Favre L, Pioche-Durieu C, Robert A, Meurice G, Le Gentil M, Chelouah S, Martin-Garcia N, Le Cam E, Guettier C, Raphaël M, Vassilev LT, Gaulard P, Codogno P, Lipinski M, Wiels J.

Autophagy. 2015;11(12):2275-87. doi: 10.1080/15548627.2015.1115939.

43.

Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.

Malouf GG, Tahara T, Paradis V, Fabre M, Guettier C, Yamazaki J, Long H, Lu Y, Raynal NJ, Jelinek J, Mouawad R, Khayat D, Brugières L, Raymond E, Issa JP.

Epigenetics. 2015;10(9):872-81. doi: 10.1080/15592294.2015.1076955.

44.

Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.

Benzoubir N, Mussini C, Lejamtel C, Dos Santos A, Guillaume C, Desterke C, Samuel D, Bréchot C, Bourgeade MF, Guettier C.

PLoS One. 2015 Jun 25;10(6):e0130559. doi: 10.1371/journal.pone.0130559. eCollection 2015.

45.

The Reg3α (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver Failure.

Moniaux N, Darnaud M, Garbin K, Dos Santos A, Guettier C, Samuel D, Amouyal G, Amouyal P, Bréchot C, Faivre J.

PLoS One. 2015 May 4;10(5):e0125584. doi: 10.1371/journal.pone.0125584. eCollection 2015.

46.

Liver metastases from meningeal hemangiopericytoma.

De Martin E, Coilly A, Guettier C, Samuel D.

Liver Int. 2015 Oct;35(10):2337. doi: 10.1111/liv.12855. Epub 2015 May 28. No abstract available.

PMID:
25913235
47.

Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.

Dalmasso C, Carpentier W, Guettier C, Camilleri-Broët S, Borelli WV, Campos Dos Santos CR, Castaing D, Duclos-Vallée JC, Broët P.

BMC Cancer. 2015 Mar 14;15:126. doi: 10.1186/s12885-015-1111-6.

48.

The groin: an unusual location of endometriosis-a multi-institutional clinicopathological study.

Mourra N, Cortez A, Bennis M, Guettier C, Zaatari G, Duvillard P, Validire P, Balaton A.

J Clin Pathol. 2015 Jul;68(7):579-81. doi: 10.1136/jclinpath-2014-202812. Epub 2015 Mar 18. No abstract available.

PMID:
25788452
49.

[One day diagnosis for breast lesions: Medical and psychological assessment--EVADIASEIN study].

Berman A, Teig B, Duracinsky M, Gayet M, Bellin MF, Guettier C, Fernandez H, Nazac A.

J Gynecol Obstet Biol Reprod (Paris). 2016 Jan;45(1):21-8. doi: 10.1016/j.jgyn.2015.01.003. Epub 2015 Feb 25. French.

50.

Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.

Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, Cassio D, Jacquemin E.

Hepatology. 2015 Aug;62(2):558-66. doi: 10.1002/hep.27767. Epub 2015 Apr 8.

PMID:
25716872

Supplemental Content

Loading ...
Support Center